Skip to main content
OpenTrials
Completed

NCT Number: NCT01879111

Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback

Out-patients with coronary heart disease or hypertension will fill out a depression screening questionnaire while waiting in a cardiac clinic. Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment. Patients in the control group receive no direct screening-feedback but their cardiologist will be informed about the screening result. All patients with a positive screening-result will be contacted after one month and six months and asked for symptoms of depression, and their use of health care. The aim of this study is to evaluate the efficiency of this minimal intervention on the course of depressive symptom in patients with known coronary heart disease or hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Episode Cardiovascular Diseases Chronic Ischaemic Heart Disease Hypertension Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cardiologicum Hamburg, Hamburg, Germany

Loading trial locations.

About this study

The aim of this study is to evaluate the efficiency of a minimal intervention on the course of depressive symptoms in patients with known coronary heart disease (CHD) or hypertension. By means of a depression screening and individual patient-targeted feedback the level of depression should decrease, the percentage of treated depressed patients should increase and health economic costs should be lowered. The main hypothesis is that screening plus targeted feedback results in a greater reduction of depression than screening only.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gender: Both, male and female
  • Minimum Age: 18 Years
  • Maximum Age: no maximum age
  • Attendance in a cardiac clinic;
  • Clinical diagnosis of coronary heart disease or hypertension;
  • Age ≥ 18 years;
  • Sufficient language skills;
  • Informed consent

Exclusion criteria

  • Life threatening health status;
  • Severe somatic or/and psychological disorder that needs urgent treatment;
  • Acute suicidal tendency;
  • Severe cognitive or/and visual difficulties;
  • Not being able to fill out questionnaires

Treatment and study plan

Patient-targeted feedback

Other

Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment.

Primary outcomes

  1. Level of depression one month after screening (Patient Health Questionnaire-9)

    Time frame: One month after depression screening

Secondary outcomes

  1. Level of depression six months after screening (Patient Health Questionnaire-9)

    Time frame: One month and six months after screening

  2. Proportion of patients treated for depression.

    Time frame: One month and six months after screening

  3. Direct and indirect health costs

    Time frame: One month and six months after screening

  4. Quality-adjusted years of life and quality of life (EuroQol-5D)

    Time frame: One month and six months after screening

Sponsors and collaborators

Lead sponsor

Universitätsklinikum Hamburg-Eppendorf

Other

Collaborators

  • German Federal Ministry of Education and Research

Registry information

Official study title

Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback: Randomized Controlled Trial

Acronym: DEPSCREEN-INFO

Important dates

Study start
2011
Primary completion
2013
Study completion
2014
First posted
Jun 17, 2013
Registry last updated
Nov 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.